← Back to Search

Behavioral Intervention

Personalized Mobile Intervention for Suicide Prevention

N/A
Recruiting
Research Sponsored by Butler Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18 and 26
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial will test a new suicide prevention mobile app to see if it is safe and effective.

Who is the study for?
This trial is for young adults aged 18-26 who have had suicidal thoughts or behaviors in the last month. Participants must be stable enough to engage with the study, comfortable using smartphones, and proficient in English. Those with severe psychotic or manic symptoms that could disrupt participation are not eligible.Check my eligibility
What is being tested?
The MAPS mobile application is being tested for its effectiveness in preventing suicide among young adults. The study will assess how feasible and acceptable this technology is, as well as its safety and impact on reducing suicidal ideation, behavior, and re-hospitalization rates.See study design
What are the potential side effects?
Since MAPS is a mobile application intervention rather than a medication, traditional side effects are not applicable. However, participants may experience emotional discomfort when discussing sensitive topics like suicide during the use of the app.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 26 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of MAPS Intervention
Acceptability of Research (Dropout)
Acceptability of Research (Recruitment)
+4 more
Secondary outcome measures
Rehospitalization
Suicidal Ideation and Behavior

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mobile Application to Prevent Suicide (MAPS)Experimental Treatment1 Intervention
Participants receiving MAPS will receive the Safety Planning Intervention (SPI) which will be uploaded into the smartphone app. They will be prompted four times per day to complete a brief ecological momentary assessment "check-in" inquiring about their cognitions, affect, and behavior, including suicidal thoughts and behaviors. Based on these responses, they will be provided with coping strategies from their safety plans and from a database of coping strategies created by study staff. They will also have access to emergency phone numbers, the coping strategies database, and can communicate with their study clinician through a text-like interface in the app. They will receive this intervention for one month.

Find a Location

Who is running the clinical trial?

Butler HospitalLead Sponsor
129 Previous Clinical Trials
16,408 Total Patients Enrolled
11 Trials studying Suicide
651 Patients Enrolled for Suicide
American Foundation for Suicide Prevention (AFSP)UNKNOWN
1 Previous Clinical Trials
10 Total Patients Enrolled
1 Trials studying Suicide
10 Patients Enrolled for Suicide

Media Library

Mobile Application to Prevent Suicide (MAPS) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05180331 — N/A
Suicide Research Study Groups: Mobile Application to Prevent Suicide (MAPS)
Suicide Clinical Trial 2023: Mobile Application to Prevent Suicide (MAPS) Highlights & Side Effects. Trial Name: NCT05180331 — N/A
Mobile Application to Prevent Suicide (MAPS) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05180331 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to participate in this clinical trial?

"Clinicaltrials.gov informs us that, despite being initially posted on October 1st 2022 and last edited on August 19th 2022, this trial is not presently recruiting patients. Nevertheless, there are currently 240 other clinical trials circulating for new participants to join."

Answered by AI

Of what demographic is this trial most suitable for participation?

"This trial is seeking 10 individuals aged 18-26 with parasuicide to take part. In addition, participants must be proficient in the use of smartphone technology and deemed by a medical team as being well enough for study proceedings."

Answered by AI

Does this clinical trial include seniors as participants?

"This trial is limited to individuals aged 18-26, with 83 studies that accept minors and 152 trials available for seniors."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial
2023. "Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05180331.
~2 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top